Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

SOLACI Peripheral Registry Hits the 1000-Patient Mark

We are very proud to say that our multicenter, prospective research registry continues to grow by leaps and bounds.

We want to congratulate the 36 centers from the 9 participating countries and invite the entire community to join this research initiative that aims to collect data on the reality of lower limb angioplasty in Latin America, in order to unify criteria, draw conclusions, and develop strategies to improve daily practice for these procedures.

To be part of the SOLACI PERIPHERAL Registry or learn more about it, contact research@solaci.org

It should be noted that SOLACI Peripheral is a research program open to all centers in Latin America that may be willing to actively participate; in this sense, each participant center will have access to registry data in real time. Furthermore, participants will have authorship rights in all Registry publications and will secure the possibility of using Registry data for their own research projects. 

The benefits of participating

  1. Access our own database dedicated to lower limb angioplasty, with unified criteria across Latin American centers.
  2. Analyze outcomes in real time with data from your own center.
  3. Interact with centers across the region interested in promoting research and furthering publishing.
  4. Present SOLACI Peripheral outcomes at local and international events.
  5. Benefit from SOLACI Research assistance to develop your research projects and/or statistical analysis. 
  6. Work closely with SOLACI Research, who will oversee your progress weekly and will make sure all data be used correctly from start to finish, with annual (mandatory) followup.

Your participation is really important to SOLACI and to the entire SOLACI Peripheral Committee. We would be pleased and honored to have you join us in this important initiative.

To take part of SOLACI Peripheral Registry, please email us to: research@solaci.org


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Relive SOLACI’s participation in the V International Congress of Clinical and Interventional Cardiology in the Dominican Republic

The Latin American Society of Interventional Cardiology actively participated in the “V International Congress of Clinical and Interventional Cardiology”, organized by the Asociación Dominicana...

SOLACI to Participate in EuroPCR 2026 with a Scientific Session Focused on the Management of Complex Coronary Lesions

The Latin American Society of Interventional Cardiology will have a prominent participation at EuroPCR 2026 through an institutional scientific session bringing together renowned international...

The Preliminary Scientific Program for SOLACI & SBHCI 2026 Is Now Available

The SOLACI & SBHCI 2026 Congress is already beginning to take shape with the official release of its Preliminary Scientific Program — a high-impact...

SOLACI granted its scientific endorsement to CITIC 2026

The Latin American Society of Interventional Cardiology (SOLACI) has granted its scientific endorsement to CITIC 2026, one of the region’s leading academic and technological...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...